Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by waldenpawnedon Mar 27, 2017 7:53pm

165 Views

Post# 26037973

RE:Medicure builds on success with major U.S. investment

Thanks for posting the article, bwaiting12. I have to admit that I hadn't given much value to the potential revenue Apicore offers through APIs developed with companies other than Medicure. Now I will! I particularly liked this line from one of the analysts: "It is like a royalty for Apicore and therefore for Medicure".

Does anyone out there have any doubt that Medicure will exercise its option to purchase the rest (almost) of Apicore by July 3, 2017?

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading